Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase

Csaba Szabo, László Virág, Salvatore Cuzzocrea, Gwen S. Scott, Paul Hake, Michael P. O'Connor, Basilia Zingarelli, Andrew Salzman, Ernest Kun

Research output: Contribution to journalArticle

263 Citations (Scopus)

Abstract

Peroxynitrite, a cytotoxic oxidant formed from nitric oxide (NO) and superoxide, induces DNA strand breakage, which activates the nuclear enzyme poly(ADP-ribose) synthase (PARS; EC 2.4.2.30). The cellular function of PARS was determined in fibroblast lines from PARS knockout animals (PARS(-/-)) and corresponding wild-type animals (PARS(+/+)), with the aid of lipophilic PARS inhibitor 5-iodo-6-amino-1,2-benzopyrone (INH2BP). We investigated the role of PARS in peroxynitrite-induced fibroblast injury in vitro and also in the development of arthritis in vivo. Exposure of embryonic fibroblasts from the PARS(+/+) animals to peroxynitrite caused DNA single-stand breakage and PARS activation and caused an acute suppression of mitochondrial respiration. INH2BP protected the PARS(+/+) cells against the suppression of mitochondrial respiration in response to peroxynitrite (50-100 μM). Similarly to PARS inhibition with INH2BP, the PARS(-/-) cells were protected against peroxynitrite-induced injury. The protection against cellular injury by PARS(-/-) phenotype or INH2BP waned when cells were challenged with higher concentrations of the oxidant. Inhibition of PARS by INH2BP or by PARS(-/-) phenotype reduced inducible nitric-oxide synthase (iNOS; EC 1.14.13.39) mRNA levels and inhibited production of NO in immunostimulated cells. INH2BP had no peroxynitrite scavenging or hydroxyl radical scavenging effects, and it exerted no additional (nonspecific) effects in the PARS(-/-) cells. In collagen-induced arthritis, significant staining for nitrotyrosine, a marker of peroxynitrite formation, was found in the inflamed joints. Oral treatment with INH2BP (0.5 g/kg, daily), starting at the onset of arthritis (day 25), delayed the development of the clinical signs at days 26-35 and improved histological status in the knee and paw. Our data demonstrate that deletion of PARS by genetic manipulation or pharmacological inhibition of PARS protects against oxidant-induced cellular injury in vitro and exhibits anti-inflammatory effects in vivo.

Original languageEnglish (US)
Pages (from-to)3867-3872
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume95
Issue number7
DOIs
StatePublished - Mar 31 1998
Externally publishedYes

Fingerprint

Peroxynitrous Acid
Poly(ADP-ribose) Polymerases
Arthritis
Fibroblasts
Wounds and Injuries
Oxidants
Nitric Oxide
Respiration
Phenotype
Wild Animals
Experimental Arthritis
DNA
Nitric Oxide Synthase Type II
5-iodo-6-amino-1,2-benzopyrone
Superoxides
Hydroxyl Radical
Knee
Anti-Inflammatory Agents
Joints
Pharmacology

Keywords

  • DNA single-strand break
  • Inducible nitric-oxide synthase
  • Inflammation
  • Nitric oxide
  • Superoxide

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase. / Szabo, Csaba; Virág, László; Cuzzocrea, Salvatore; Scott, Gwen S.; Hake, Paul; O'Connor, Michael P.; Zingarelli, Basilia; Salzman, Andrew; Kun, Ernest.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 95, No. 7, 31.03.1998, p. 3867-3872.

Research output: Contribution to journalArticle

Szabo, Csaba ; Virág, László ; Cuzzocrea, Salvatore ; Scott, Gwen S. ; Hake, Paul ; O'Connor, Michael P. ; Zingarelli, Basilia ; Salzman, Andrew ; Kun, Ernest. / Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase. In: Proceedings of the National Academy of Sciences of the United States of America. 1998 ; Vol. 95, No. 7. pp. 3867-3872.
@article{3ddbafab3b7b4d41abe43f5fd461d47b,
title = "Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase",
abstract = "Peroxynitrite, a cytotoxic oxidant formed from nitric oxide (NO) and superoxide, induces DNA strand breakage, which activates the nuclear enzyme poly(ADP-ribose) synthase (PARS; EC 2.4.2.30). The cellular function of PARS was determined in fibroblast lines from PARS knockout animals (PARS(-/-)) and corresponding wild-type animals (PARS(+/+)), with the aid of lipophilic PARS inhibitor 5-iodo-6-amino-1,2-benzopyrone (INH2BP). We investigated the role of PARS in peroxynitrite-induced fibroblast injury in vitro and also in the development of arthritis in vivo. Exposure of embryonic fibroblasts from the PARS(+/+) animals to peroxynitrite caused DNA single-stand breakage and PARS activation and caused an acute suppression of mitochondrial respiration. INH2BP protected the PARS(+/+) cells against the suppression of mitochondrial respiration in response to peroxynitrite (50-100 μM). Similarly to PARS inhibition with INH2BP, the PARS(-/-) cells were protected against peroxynitrite-induced injury. The protection against cellular injury by PARS(-/-) phenotype or INH2BP waned when cells were challenged with higher concentrations of the oxidant. Inhibition of PARS by INH2BP or by PARS(-/-) phenotype reduced inducible nitric-oxide synthase (iNOS; EC 1.14.13.39) mRNA levels and inhibited production of NO in immunostimulated cells. INH2BP had no peroxynitrite scavenging or hydroxyl radical scavenging effects, and it exerted no additional (nonspecific) effects in the PARS(-/-) cells. In collagen-induced arthritis, significant staining for nitrotyrosine, a marker of peroxynitrite formation, was found in the inflamed joints. Oral treatment with INH2BP (0.5 g/kg, daily), starting at the onset of arthritis (day 25), delayed the development of the clinical signs at days 26-35 and improved histological status in the knee and paw. Our data demonstrate that deletion of PARS by genetic manipulation or pharmacological inhibition of PARS protects against oxidant-induced cellular injury in vitro and exhibits anti-inflammatory effects in vivo.",
keywords = "DNA single-strand break, Inducible nitric-oxide synthase, Inflammation, Nitric oxide, Superoxide",
author = "Csaba Szabo and L{\'a}szl{\'o} Vir{\'a}g and Salvatore Cuzzocrea and Scott, {Gwen S.} and Paul Hake and O'Connor, {Michael P.} and Basilia Zingarelli and Andrew Salzman and Ernest Kun",
year = "1998",
month = "3",
day = "31",
doi = "10.1073/pnas.95.7.3867",
language = "English (US)",
volume = "95",
pages = "3867--3872",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "7",

}

TY - JOUR

T1 - Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase

AU - Szabo, Csaba

AU - Virág, László

AU - Cuzzocrea, Salvatore

AU - Scott, Gwen S.

AU - Hake, Paul

AU - O'Connor, Michael P.

AU - Zingarelli, Basilia

AU - Salzman, Andrew

AU - Kun, Ernest

PY - 1998/3/31

Y1 - 1998/3/31

N2 - Peroxynitrite, a cytotoxic oxidant formed from nitric oxide (NO) and superoxide, induces DNA strand breakage, which activates the nuclear enzyme poly(ADP-ribose) synthase (PARS; EC 2.4.2.30). The cellular function of PARS was determined in fibroblast lines from PARS knockout animals (PARS(-/-)) and corresponding wild-type animals (PARS(+/+)), with the aid of lipophilic PARS inhibitor 5-iodo-6-amino-1,2-benzopyrone (INH2BP). We investigated the role of PARS in peroxynitrite-induced fibroblast injury in vitro and also in the development of arthritis in vivo. Exposure of embryonic fibroblasts from the PARS(+/+) animals to peroxynitrite caused DNA single-stand breakage and PARS activation and caused an acute suppression of mitochondrial respiration. INH2BP protected the PARS(+/+) cells against the suppression of mitochondrial respiration in response to peroxynitrite (50-100 μM). Similarly to PARS inhibition with INH2BP, the PARS(-/-) cells were protected against peroxynitrite-induced injury. The protection against cellular injury by PARS(-/-) phenotype or INH2BP waned when cells were challenged with higher concentrations of the oxidant. Inhibition of PARS by INH2BP or by PARS(-/-) phenotype reduced inducible nitric-oxide synthase (iNOS; EC 1.14.13.39) mRNA levels and inhibited production of NO in immunostimulated cells. INH2BP had no peroxynitrite scavenging or hydroxyl radical scavenging effects, and it exerted no additional (nonspecific) effects in the PARS(-/-) cells. In collagen-induced arthritis, significant staining for nitrotyrosine, a marker of peroxynitrite formation, was found in the inflamed joints. Oral treatment with INH2BP (0.5 g/kg, daily), starting at the onset of arthritis (day 25), delayed the development of the clinical signs at days 26-35 and improved histological status in the knee and paw. Our data demonstrate that deletion of PARS by genetic manipulation or pharmacological inhibition of PARS protects against oxidant-induced cellular injury in vitro and exhibits anti-inflammatory effects in vivo.

AB - Peroxynitrite, a cytotoxic oxidant formed from nitric oxide (NO) and superoxide, induces DNA strand breakage, which activates the nuclear enzyme poly(ADP-ribose) synthase (PARS; EC 2.4.2.30). The cellular function of PARS was determined in fibroblast lines from PARS knockout animals (PARS(-/-)) and corresponding wild-type animals (PARS(+/+)), with the aid of lipophilic PARS inhibitor 5-iodo-6-amino-1,2-benzopyrone (INH2BP). We investigated the role of PARS in peroxynitrite-induced fibroblast injury in vitro and also in the development of arthritis in vivo. Exposure of embryonic fibroblasts from the PARS(+/+) animals to peroxynitrite caused DNA single-stand breakage and PARS activation and caused an acute suppression of mitochondrial respiration. INH2BP protected the PARS(+/+) cells against the suppression of mitochondrial respiration in response to peroxynitrite (50-100 μM). Similarly to PARS inhibition with INH2BP, the PARS(-/-) cells were protected against peroxynitrite-induced injury. The protection against cellular injury by PARS(-/-) phenotype or INH2BP waned when cells were challenged with higher concentrations of the oxidant. Inhibition of PARS by INH2BP or by PARS(-/-) phenotype reduced inducible nitric-oxide synthase (iNOS; EC 1.14.13.39) mRNA levels and inhibited production of NO in immunostimulated cells. INH2BP had no peroxynitrite scavenging or hydroxyl radical scavenging effects, and it exerted no additional (nonspecific) effects in the PARS(-/-) cells. In collagen-induced arthritis, significant staining for nitrotyrosine, a marker of peroxynitrite formation, was found in the inflamed joints. Oral treatment with INH2BP (0.5 g/kg, daily), starting at the onset of arthritis (day 25), delayed the development of the clinical signs at days 26-35 and improved histological status in the knee and paw. Our data demonstrate that deletion of PARS by genetic manipulation or pharmacological inhibition of PARS protects against oxidant-induced cellular injury in vitro and exhibits anti-inflammatory effects in vivo.

KW - DNA single-strand break

KW - Inducible nitric-oxide synthase

KW - Inflammation

KW - Nitric oxide

KW - Superoxide

UR - http://www.scopus.com/inward/record.url?scp=0032584164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032584164&partnerID=8YFLogxK

U2 - 10.1073/pnas.95.7.3867

DO - 10.1073/pnas.95.7.3867

M3 - Article

VL - 95

SP - 3867

EP - 3872

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 7

ER -